BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38542507)

  • 21. miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia.
    Gunawan RR; Astuti I; Danarto HR
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):1095-1099. PubMed ID: 36974566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
    Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.
    Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
    Pathol Biol (Paris); 2014 Jun; 62(3):129-36. PubMed ID: 24745345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells.
    Ariotti N; Wu Y; Okano S; Gambin Y; Follett J; Rae J; Ferguson C; Teasdale RD; Alexandrov K; Meunier FA; Hill MM; Parton RG
    Autophagy; 2021 Sep; 17(9):2200-2216. PubMed ID: 32897127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics in diagnosis of prostate cancer.
    Davalieva K; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade.
    Schmidt B; Anastasiadis AG; Seifert HH; Franke KH; Oya M; Ackermann R
    Anticancer Res; 2003; 23(5A):3991-9. PubMed ID: 14666708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
    Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
    Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
    Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y
    Crit Rev Oncol Hematol; 2020 Jan; 145():102860. PubMed ID: 31874447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
    Worst TS; von Hardenberg J; Gross JC; Erben P; Schnölzer M; Hausser I; Bugert P; Michel MS; Boutros M
    Mol Cell Proteomics; 2017 Jun; 16(6):998-1008. PubMed ID: 28396511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-20b-5p is a novel biomarker for detecting prostate cancer.
    Zhai TY; Dou M; Ma YB; Wang H; Liu F; Zhang LD; Chong T; Wang ZM; Xue L
    Oncol Lett; 2022 Dec; 24(6):426. PubMed ID: 36311688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies.
    Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Ben Rais N; Ouertani L; Nouira Y; Horchani A; Oueslati R
    J Exp Clin Cancer Res; 2010 Dec; 29(1):171. PubMed ID: 21189143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy.
    Du X; Dong Y; Liu J; Su Y; Zhu Y; Pan J; Dong B; Chen R; Liu J; Tong Z; Pienta KJ; Rowe SP; Dong L; Xue W
    Prostate; 2023 Aug; 83(11):1112-1120. PubMed ID: 37165552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment.
    Li Q; Hu J; Shi Y; Xiao M; Bi T; Wang C; Yan L; Li X
    Cell Cycle; 2021 Dec; 20(23):2531-2546. PubMed ID: 34724861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients.
    Logozzi M; Angelini DF; Iessi E; Mizzoni D; Di Raimo R; Federici C; Lugini L; Borsellino G; Gentilucci A; Pierella F; Marzio V; Sciarra A; Battistini L; Fais S
    Cancer Lett; 2017 Sep; 403():318-329. PubMed ID: 28694142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker.
    Škara L; Vodopić T; Pezelj I; Abramovic I; Vrhovec B; Vrtarić A; Sincic N; Tomas D; Bulimbašić S; Kuliš T; Ulamec M
    Biomol Biomed; 2023 Feb; 23(1):176-186. PubMed ID: 36036057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.
    Kharmate G; Hosseini-Beheshti E; Caradec J; Chin MY; Tomlinson Guns ES
    PLoS One; 2016; 11(5):e0154967. PubMed ID: 27152724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X; Foj L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.